#Microbiota #Depression #Alzheimer
#Neuroinflammation #AntiInflammatoryDiet
Mental disorders such as depression, anxiety,
bipolar disorder, or schizophrenia—as well as neurodegenerative diseases like
Alzheimer’s or Parkinson’s—are major global public health concerns. Their
prevalence continues to grow,
treatments remain imperfect, and
their origins
are multifactorial.
Despite pharmacological advances,
conventional
treatments are often ineffective for a subset of patients, poorly tolerated, or
not well suited for chronic forms.
Low-grade chronic inflammation, long
overlooked, is now emerging as a key factor in the pathophysiology of many
psychiatric and neurodegenerative conditions.
In response to these limitations,
diet—especially
anti-inflammatory dietary patterns—is attracting increasing
interest. By acting on the microbiota, cytokines, oxidative stress, and innate
immunity, certain dietary models could modulate neuroinflammatory status and
improve clinical symptoms. This review explores the potential role of an
anti-inflammatory diet as a therapeutic tool for psychiatric and
neurodegenerative disorders.
Can Brain Inflammation Be Eaten Away?
The authors describe how systemic
inflammation—via pro-inflammatory cytokines such as IL-6, TNF-α, and CRP—can
disrupt brain function. These
inflammatory mediators, associated with increased
intestinal permeability, an imbalanced microbiota, and dysregulation of the
gut-brain axis, play a central role in
cognitive decline and mood disorders.
Epidemiological data indicate that
diets rich
in fruits, vegetables, omega-3s, fiber, and minimally processed foods—such as
the Mediterranean or DASH diets—are associated with a
reduced risk of
depression, cognitive decline, and Alzheimer’s disease. In contrast, a
Western-style diet rich in saturated fats, added sugars, and ultra-processed
foods promotes chronic inflammation and worsens psychiatric symptoms.
Several small clinical trials have tested
anti-inflammatory diets in patients with mental or cognitive disorders. They
report
improvements in mood, anxiety, and some cognitive functions. However,
these results are still limited due to the variability in dietary patterns
tested, short intervention durations, and small sample sizes.
Read next: Neurodegeneration: the shadow of a deficiency?
Food to Soothe the Brain?
Psychiatric and neurodegenerative disorders
share a common inflammatory background—often silent, yet biologically active.
Their management remains therapeutically challenging, especially in patients
resistant to standard treatments. This review examines the potential of
targeted nutrition to modulate brain inflammation and alleviate related
symptoms.
Findings suggest that an
anti-inflammatory diet
could offer a promising complementary approach. It could help restore
neuroimmune balance through
actions on the gut microbiota, the blood-brain
barrier, and the production of neurotransmitters.
However, the evidence is still weak. Clinical
studies are often small, uncontrolled, or short-term. Dietary protocols lack
standardization, and the very definition of an “anti-inflammatory diet” remains
unclear. Further randomized controlled trials are needed to
assess actual
efficacy, identify the most responsive patient populations, and clarify
specific mechanisms of action. Identifying biomarkers of dietary response could
also enable a more personalized nutritional approach.
Read next: Parkinson’s disease: could it all start in the gut?
